Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2022 4
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
ASO Visual Abstract: Comparative Study on Efficacy and Safety of Radical Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Locally Advanced Gastric Cancer A Propensity Score Matching Analysis.
Shen C, Lin Y, Guo X, Li Y, Wang D, Du Z, Hu P, Chen X, Zeng X, Lv J, Wu C, Tao K. Shen C, et al. Among authors: lv j. Ann Surg Oncol. 2022 Dec;29(13):8564-8565. doi: 10.1245/s10434-022-12482-4. Ann Surg Oncol. 2022. PMID: 36071339 No abstract available.
Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (S-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: Early results of a phase 2, single-arm trial.
Yin Y, Lin Y, Yang M, Lv J, Liu J, Wu K, Liu K, Li A, Shuai X, Cai K, Wang Z, Wang G, Shen J, Zhang P, Tao K. Yin Y, et al. Among authors: lv j. Front Oncol. 2022 Aug 30;12:959295. doi: 10.3389/fonc.2022.959295. eCollection 2022. Front Oncol. 2022. PMID: 36158692 Free PMC article.
Comparative Study of Short-Term Efficacy and Safety of Mitomycin versus Lobaplatin for Hyperthermic Intraperitoneal Chemotherapy after Radical Surgery in Colorectal Cancer with High-Risk Factors for Peritoneal Carcinomatosis: A Propensity Score Matching Analysis.
Guo X, Lin Y, Shen C, Li Y, Xiang F, Ruan T, Zeng X, Lv J, Tao K, Wu C. Guo X, et al. Among authors: lv j. Curr Oncol. 2023 Jan 21;30(2):1488-1501. doi: 10.3390/curroncol30020114. Curr Oncol. 2023. PMID: 36826075 Free PMC article.